Drug profile · INN
nivolumab
OPDIVO
- US status
- approved
- Patents linked
- 0
- News articles
- 2
Quick answer
nivolumab (OPDIVO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
Related news
FDA Approves Opdivo for Advanced Renal Cell Carcinoma
The FDA has approved Opdivo for the treatment of advanced renal cell carcinoma, marking a significant advancement in cancer therapy options for patients.
FDA Approves Opdivo Plus Chemotherapy for Gastric Cancer
The FDA has approved Opdivo in combination with chemotherapy for the treatment of gastric cancer, marking a significant advancement in cancer care.
Frequently asked questions
What is nivolumab?
nivolumab (OPDIVO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for nivolumab?
OPDIVO is a marketed brand name for nivolumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nivolumab?
nivolumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.